The New York University School of Medicine is one of the graduate schools of New York University. Founded in 1841 as the University Medical College.The School of Medicine is part of New York University Medical Center. It is located at 550 First Avenue. The School of Medicine has 360 full-time faculty and 175 part-time faculty. Additionally, there are 26 endowed professorships, 975 residents/fellows, 76 M.D./Ph.D. candidates and 788 post-graduate registrants as of 2007. The NYU Medical Center is home to the School of Medicine, the Sackler Institute of Graduate Biomedical Sciences, and the Charles C. Harris Skin & Cancer Pavilion, considered the most prestigious dermatology institute in the United States. In the 2007 U.S. News & World Report, NYU Medical Center ranked among the top 20 in the nation in cardiology, geriatrics, neurology, orthopedics, psychiatry, rehabilitation and rheumatology. Overall, it was ranked among premier hospitals in the nation for 12 different specialties.

the FDA claims ignorance of phthalates, and has no plans to begin testing without first consulting with their corporate overlords. The FDA would prefer if "data would emerge" proffered from the Lady In the Lake, or from Mount Sinai, or somewhere mythical. The FDA is too busy to conduct any studies on their own.

Dr. Weinberg is certified by the American Board of Plastic Surgery since 1982. He is a Clinical Professor of Plastic Surgery at Mount Sinai Hospital and has extensive experience in plastic and aesthetic surgery of the breast. Dr. Weinberg believes successful plastic surgery is a result of a good rapport between patient and surgeon. He works clo

Researchers at New York’s Mount Sinai School of Medicine have found a surprising link between traumatic brain injury and social and mental dysfunction.

With the aim of becoming a top employer, Mount Sinai conducted an employee survey and found that employees had a strong need to receive regular, fair and consistent feedback on performance.

Chronic pain can be successfully treated with a novel targeted gene therapy, according to researchers in the Department of Medicine and Department of Neurosciences at Mount Sinai School of Medicine.